What Genesis Biosciences does

Genesis Biosciences is a privately held industrial biosciences company founded in 1998 by Conrad Mielcuszny, headquartered in Lawrenceville, Georgia (US) with a European technical hub in Cardiff, UK. The company develops and manufactures microbial and antimicrobial products built on its proprietary eco-benign® chemistry platform and in-house Bacillus fermentation capabilities — including vessel capacity from benchtop to 30,000L plus spray drying and downstream processing. Its product portfolio spans four sub-brands: Evogen (application-specific microbial powders, liquids, and solid blocks for animal waste, aquaculture, bioremediation, food processing, grease traps, hard-surface and floor cleaning, laundry, odor control, septic, and industrial/municipal wastewater); Evozyme (five-strain Bacillus formulations for manufacturers and formulators); Evobac (surfactant-free biological broths for formulators in aquaculture and wastewater); and Biosan (vapor-phase antimicrobial sanitary and feminine hygiene deodorizers based on 700+ qualified natural plant extracts). Genesis also offers contract R&D services including custom formulation, feasibility studies, stability trials, validation, and scale-up transfer.

The company generates revenue through direct B2B product sales across five primary verticals — agriculture and animal husbandry, wastewater and environmental treatment, facilities management and cleaning, bioremediation and disaster response, and sanitary/feminine hygiene — supported by a dedicated technical sales support team, plus contract R&D services for third-party formulators. GTM is sales-led with no disclosed pricing; products are sold via direct sales channels into more than 50 countries from the two regional hubs. Quality and regulatory positioning is a material differentiator: both facilities hold ISO 9001:2015 (US since 2014, EU since 2010), the European site has held ISO 14001 since 2013, and the company achieved FSSC 22000 certification in 2020-2021 alongside active HACCP, ISO 22000, cGMP, and FSMA compliance programs.

The business is privately held with no disclosed external investors, no parent entity, and no public financials. Recent operating history shows a multi-year capex program — Phase 1 facility improvements (2018), Building 3 fermentation suite (2020), and a 12,000 sq ft US extension (2021) — coupled with recognition at the Cardiff Business Awards (multiple 2019-2021 categories), the Wales STEM Awards (2020), the Welsh National Environmental Award (2021), and the Prestige South East USA Science & Technology Company of the Year (2022). The strategic thrust signaled by the FSSC 22000 build-out is expansion from industrial cleaning and waste treatment into regulated animal and human probiotics.

Name

Genesis Biosciences

Legal name

Genesis Biosciences, LLC

Website

https://genesisbiosciences.us

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

101–250 employees

Short description

Genesis Biosciences is a privately held biosciences company that develops microbial and antimicrobial products based on proprietary eco-benign® chemistry and Bacillus fermentation, selling direct to B2B customers across food processing, wastewater treatment, facilities management, animal husbandry, aquaculture, and sanitary hygiene in over 50 countries.

Ownership category

akta.pro rank

Product category

Industrial Biotechnology Products

NAICS

Food Manufacturing (311)

SIC

Industrial Organic Chemicals (2860), Food And Kindred Products (2000)

akta.pro primary industry

Biological Formulation, Fermentation & Scale-Up Manufacturing (AFABAEAM)

akta.pro secondary industries

Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids) (EUAAAIAL), Natural Antimicrobials & Clean-Label Preservatives (Plant Extracts, Essential Oils, Fermented Extracts) (AFAJAFAF)

Keywords

• Microbial cleaning products
• Wastewater treatment solutions
• Bioremediation products
• Antimicrobial formulations
• Fermentation services

Headquarters

HQ city

Lawrenceville

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Microbial Products: Sale of performance-driven microbial products (Evogen, Evozyme ranges) for applications including cleaning, wastewater treatment, animal feeds, aquaculture, and bioremediation. Products available in powder, liquid, and solid formats.
2. Antimicrobial Products: Sale of vapor-phase antimicrobial products (Biosan range) based on natural plant extracts and essential oils for sanitary waste odor control.
3. Biological Broth Formulations: Sale of Evobac biological broth formulations for use by formulators in developing their own biological chemical products. Surfactant-free formulations for aquaculture and wastewater treatment applications.
4. Contract R&D Services: Custom product formulation and design, feasibility studies, stability trials, product validation studies, and product scale-up/transfer to manufacture services for customers.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Genesis Biosciences manufactures and sells microbial and antimicrobial products built on its proprietary eco-benign® chemistry platform. The product portfolio includes the Evogen, Evozyme, and Evobac microbial lines (powders, liquids, and solids) for cleaning, wastewater treatment, animal feeds, aquaculture, and bioremediation, plus the Biosan line of natural essential-oil-based antimicrobial deodorizers for sanitary waste. The company also offers contract fermentation and custom product development services using in-house fermentation capacity from benchtop to 30,000-liter vessels.

Product overview

Genesis Biosciences offers a multi-brand portfolio of microbial and antimicrobial products built on its proprietary eco-benign® chemistry technology platform. The core product lines include Evogen (solution-specific microbial products available in powder, liquid, and solid formats for applications including animal waste, aquaculture, bioremediation, carpet care, floor cleaning, food processing, grease traps, hard surfaces, industrial/municipal wastewater, laundry, odor control, and septic tanks), Evozyme (multi-purpose microbial formulations with five Bacillus strains for manufacturers and formulators across cleaning, wastewater, and pond management applications), Evobac (surfactant-free biological broth formulations for aquaculture, wastewater, and applications where formulators need to add their own chemistries), and Biosan (antimicrobial sanitary waste odor control products using natural essential oils). The company also provides contract fermentation services and custom product development using their in-house fermentation capabilities ranging from benchtop to 30,000L vessels.

Differentiator

Problem solved

Functional benefit

Brands

• Evogen: High-quality, performance-driven, environmentally-responsible, solution-specific microbial products offering effective and sustainable alternatives to traditional chemical products across a wide range of industries.
• Evozyme
• Evobac
• Biosan
• eco-benign

Products and services

• Evogen Solution-specific microbial product line offering environmentally-responsible alternatives to traditional chemical products. Available in powder, liquid, and solid formats across applications including industrial and municipal wastewater treatment, animal waste, aquaculture, septic tanks, grease traps, bioremediation, and commercial cleaning (floor, hard surface, carpet, laundry, odor control).
• Evozyme Series of microbial formulations containing five select strains of Bacillus bacteria chosen for enzymatic capabilities to degrade organic substrates. Available in liquid, powder, and solid formats for manufacturers and formulators across cleaning, wastewater, and pond management applications.
• Evobac Performance-driven biological broth formulations for use across industries from aquaculture to wastewater treatment. Surfactant-free formulations designed for formulators developing their own biological chemical products where additional chemistries may interfere with formulations.
• Biosan Antimicrobial sanitary and feminine hygiene waste odor control product line based on natural, biodegradable raw materials and essential oils. Includes Biosan e card, Biosan Naturals, and Biosan P-max variants for deodorizing sanitary waste bins and feminine hygiene units throughout the service cycle.
• Contract R&D and Custom Product Development Services Custom product formulation and design, feasibility studies, stability trials, product validation studies, and product scale-up/transfer to manufacture services for customers, leveraging in-house fermentation capacity from benchtop to 30,000-liter vessels.

Quantifiable outcome

• Level of effectiveness exceeds most chemical disinfectants
• +1 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators5 records

Recent moves10 records

Expansion highlights6 records

Direct peers

• Novonesis (formerly Novozymes): World's largest industrial enzyme and microbial solutions company, offering Bacillus-based products, fermentation services, and bio-augmentation solutions across cleaning, wastewater, agriculture, and food processing — directly comparable product/market overlap with Genesis Biosciences.
• Lallemand: Global microbial products company with Bacillus and yeast-based solutions for animal nutrition, agriculture, wastewater, brewing, and environmental applications — directly overlapping target customers, technology (microbial fermentation), and B2B industrial go-to-market.
• AB Enzymes: Industrial enzyme manufacturer producing specialty enzymes and microbial solutions for cleaning, food processing, and animal feed — comparable scale, fermentation technology, and target customer segments to Genesis.
• Chr. Hansen (now part of Novonesis): Cultures and fermentation-derived ingredients supplier with strong positions in animal and human probiotics, food ingredients, and plant health — comparable Bacillus-based fermentation capability and product portfolio adjacency.

Broad incumbents

• Ecolab: Global leader in water, hygiene, and infection prevention with broad cleaning, sanitization, and wastewater portfolios — overlapping with Genesis in industrial/facilities cleaning and food processing sanitation, but operating at vastly greater scale and with a wider product range.
• IFF Health & Biosciences (Danisco): Large diversified ingredients company with a Health & Biosciences division producing cultures, enzymes, probiotics, and microbial solutions for food, beverage, animal nutrition, and cleaning — overlapping product categories and target customers with Genesis.
• Solenis (formerly Diversey): Large specialty chemicals and hygiene solutions provider with water treatment, cleaning, and microbial offerings — broad incumbent competing with Genesis's cleaning and wastewater product lines as part of a much larger portfolio.
• Lesaffre: Global fermentation specialist (primarily yeast) with adjacent capabilities in yeast extracts, baking enzymes, and probiotics — comparable fermentation technology base and ingredient-market orientation, but with a different primary product focus.

Emerging players

• Enzyme Innovation: US-based enzyme and microbial solutions company producing Bacillus fermentation products for cleaning, wastewater, and animal feed applications — closely comparable product line and scale to Genesis.
• Advanced BioCatalytics: Smaller biotechnology firm focused on environmentally benign bio-based chemistries and enzymes for cleaning and industrial applications — comparable eco-friendly chemistry platform and target market overlap, but at smaller scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/genesis-biosciences
• Xx.com/Genesis_Bio

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genesis Biosciences